The Role of Neopterin and Biomarkers of Inflammation in the Monitoring оf Treatment Efficacy for Pulmonary Tuberculosis

2018 ◽  
Vol 3 (7) ◽  
pp. 90-95
Author(s):  
O. O. Hovardovska ◽  
1994 ◽  
Vol 75 ◽  
pp. 29
Author(s):  
A. McDaniel ◽  
N. Schoenfeld ◽  
W. Frank ◽  
A. Grassot ◽  
H. Mauch ◽  
...  

Author(s):  
Gerwin Heller

SummaryImmunotherapy is one of the major breakthroughs in cancer treatment. However, many patients do not benefit from this type of therapy. Thus, there is an urgent need for a strategy to predict treatment efficacy before start of therapy. The role of certain genetic and epigenetic factors as potential predictive markers for response to immunotherapy is discussed in this short review.


CHEST Journal ◽  
1992 ◽  
Vol 101 (5) ◽  
pp. 1211-1214 ◽  
Author(s):  
Adelaida M. Miro ◽  
Eugene Gibilara ◽  
Steven Powell ◽  
Stephan L. Kamholz

2003 ◽  
Vol 47 (4) ◽  
pp. 317-321 ◽  
Author(s):  
David Bell ◽  
Vicky Leckie ◽  
Mike McKendrick

2021 ◽  
Author(s):  
Zehui Wang ◽  
Weiyong Zhang ◽  
Shouxia Li ◽  
Dingli Chen ◽  
Lei Wang ◽  
...  

Background: This study explored the clinical role of lncRNA MEG3 in rheumatoid arthritis (RA) management. Materials & methods: Totally, 191 active RA patients were enrolled, and their lncRNA MEG3 expressions in peripheral blood monoclonal cells were detected. Results: LncRNA MEG3 expression was downregulated, and it negatively correlated with lesion joints, inflammation and disease activity in RA patients. Moreover, lncRNA MEG3 expression was increased during treatment; meanwhile its increment correlated with treatment response and remission. Conclusion: LncRNA MEG3 may serve as a potential biomarker for monitoring treatment efficacy in RA management.


2015 ◽  
Vol 56 (2) ◽  
pp. 340
Author(s):  
Doosoo Jeon ◽  
Seung Eun Lee ◽  
Woo Hyun Cho ◽  
Byung Hee Lee ◽  
Yun Seong Kim ◽  
...  

1993 ◽  
Vol 16 (1) ◽  
pp. 41
Author(s):  
Nancy Shields ◽  
S. H. Salzman ◽  
M. L. Schindel ◽  
C. P. Aranda ◽  
R. L. Smith ◽  
...  

Author(s):  
Pradip Jain ◽  
Rakesh Kumar Jha ◽  
Ranjit S. Ambad ◽  
Archana Dhok ◽  
Prakash Kute

2020 ◽  
Vol 27 (3) ◽  
pp. 58-67
Author(s):  
Yu. V. Shubik ◽  
M. M. Medvedev ◽  
M. A. Baturova ◽  
A. E. Rivin

The indications for Holter monitoring, which are included in the new Russian guidelines on cardiac arrhythmias and conduction disturbances, are considered. Possibilities of the diagnostic approaches of arrhythmias, management algorithms and treatment efficacy and safety monitoring are discussed.


Sign in / Sign up

Export Citation Format

Share Document